Margins at Indian hospital groups are under pressure after the National Pharmaceutical Pricing Authority (NPPA) fixed the prices of stents last month, says Navneet Bali, COO of International Oncology Group Services. Subscribers login here to carry on reading.
Not a subscriber? Want to read the full stories? Why not subscribe today?
If you would like to find out more click here to request a guided tour of the website with one of the team.
We would welcome your thoughts on this story. Email your views to Claude Risner or call 0207 183 3779.
The only information source for private healthcare services in Emerging Markets, click here to download a brochure